NEI
TEVA icon

Northwest & Ethical Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Northwest & Ethical Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Sell
14,787
-17,683
-54% -$589K 0.01% 333
2026
Q1 		$968K Buy
32,470
+7,802
+32% +$251K 0.02% 316
2025
Q4 		$773K Sell
24,668
-10,781
-30% -$266K 0.02% 341
2025
Q3 		$680K Sell
35,449
-4,130
-10% -$72.5K 0.02% 374
2025
Q2 		$663K Buy
39,579
+3,900
+11% +$62.9K 0.02% 374
2025
Q1 		$548K Buy
35,679
+21,479
+151% +$384K 0.01% 382
2024
Q4 		$313K Buy
14,200
+4,200
+42% +$76.4K 0.01% 369
2024
Q3 		$180K Buy
10,000
+5,200
+108% +$91K ﹤0.01% 429
2024
Q2 		$78K Buy
+4,800
New +$73.9K ﹤0.01% 460
2018
Q4 		– Sell
-110,931
Closed -$2.39M – 404
2018
Q3 		$2.39M Buy
+110,931
New +$2.58M 0.15% 202
2017
Q2 		– Sell
-13,960
Closed -$448K – 396
2017
Q1 		$448K Sell
13,960
-41,344
-75% -$1.41M 0.03% 330
2016
Q4 		$2M Buy
55,304
+15,340
+38% +$612K 0.14% 182
2016
Q3 		$1.84M Buy
+39,964
New +$2.09M 0.13% 176
2013
Q3 		– Sell
-26,709
Closed -$1.05M – 238
2013
Q2 		$1.05M Buy
+26,709
New +$1.04M 0.08% 181

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Northwest & Ethical Investments's TEVA Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Teva Pharmaceuticals (TEVA) stake by 54% in Q2 2026, selling an estimated $589K and leaving 14,787 shares worth $493K. The position accounts for 0.01% of the portfolio, ranked #333.

Northwest & Ethical Investments first reported a position in TEVA in Q2 2013 and has held it in 14 quarters since. The position peaked at $2.39M in Q3 2018. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Northwest & Ethical Investments held 14,787 shares of Teva Pharmaceuticals worth $493K as of Q2 2026.
  • Northwest & Ethical Investments sold 17,683 Teva Pharmaceuticals shares in Q2 2026, an estimated $589K.
  • Teva Pharmaceuticals made up 0.01% of Northwest & Ethical Investments's portfolio in Q2 2026, its #333 holding.
  • Northwest & Ethical Investments first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
  • Northwest & Ethical Investments's Teva Pharmaceuticals position peaked at $2.39M in Q3 2018.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.